ARTICLE | Clinical News
Lomucin talniflumate: Development discontinued
July 9, 2007 7:00 AM UTC
GENR stopped a double-blind, placebo-controlled Phase II trial and discontinued development of Lomucin after a data monitoring committee (DMC) said there would be no additional benefit to further enro...